Keskinoglu, A.Bulut, İ.K.Taner, S.Turkes, A.Z.Kabasakal, C.2020-12-012020-12-0120200041-1345https://doi.org/10.1016/j.transproceed.2020.03.023https://hdl.handle.net/11454/61502Introduction: In this study,we investigated the presence of cytomegalovirus (CMV) infection in kidney transplanted children and its effect on kidney dysfunction. Material and Methods: One hundred thirty-five pediatric renal transplant patients were included in this study. The presence of CMV infection, CMV risk status, and other clinical features of the patients were evaluated retrospectively. Results: Fifty-three percent of all patients and 68.8% of patients with CMV were male. The mean age was 12 years in all patients and CMV groups. According to the CMV risk classification, 40.9% of the patients with CMV infection/disease were in the high-risk group (CMV D+R-). In CMV risk groups, the presence of CMV infection/disease was similar. Cold ischemia time, male sex (patients and donors), deceased donor, higher HLA-mismatches, and cumulative antithymocyte globulin dose were found as risk factors for CMV infection/disease. Acute rejection/graft failure was observed in 27% of all patients. CMV infection has no effect on rejection/graft failure and survival. Discussion: The frequency and risk factors of CMV in renal transplant children in our study were consistent with the literature. Conclusions: CMV infection was found in one-fifth of our patients and the majority (71.9%) of them developed infection in the first 6 months. In one-third of our patients acute rejection/graft failure was observed. There was no effect of CMV infection on rejection/graft failure and survival in pediatric patients with proper and effective treatment. © 2020en10.1016/j.transproceed.2020.03.023info:eu-repo/semantics/closedAccessArticle5210318631912-s2.0-8508752748532646585Q3